Cell Line Development Market to Hit USD 9.8B Revenue by 2026: Global Market Insights, Inc.

SELBYVILLE, Del., March 4, 2020 /PRNewswire/ -- Global Market Insights, Inc. has recently added a new report on the cell line development market, which estimates the global market valuation for cell line development will cross US $9.8 billion by 2026. The increasing prevalence of cancer and rising demand for vaccines globally will drive the market revenue over 2020 to 2026.

The increasing prevalence of cancer and other chronic diseases worldwide, along with the rising demand for monoclonal antibodies, will serve to major impact rendering factors in the cell line development market growth. Increasing investments in R&D activities have led to the production of cancer cell lines that are used for studying and developing adequate and effective biological therapies for cancer. Additionally, the focus of companies on the development of disease-specific cell lines will further spur the market size.

Request a sample of this research report at https://www.gminsights.com/request-sample/detail/429

Furthermore, the growing demand for monoclonal antibodies has been a boon for the market's expansion. Benefits of the monoclonal antibodies, such as growing usage in the treatment of myocardial infarctions, cancer, reversal of drug toxicity and minimal risk of allograft rejection, will upsurge its demand over the forecast period. In addition, the stability and homogenous nature of the monoclonal antibodies increase its preference over polyclonal antibodies, thereby augmenting the market value. However, a high risk of cross-contamination and stringent regulatory guidelines may restrain the cell line development market growth over the analysis timeframe.

The equipment segment held around a 52% revenue share in 2019. The equipment segment is further bifurcated into incubator, centrifuge, bioreactor, storage equipment and microscope. The rising demand for cell lines and therapeutics will prove beneficial for the market growth. The usage of incubator and storage equipment for appropriate growth and storage of cell lines will surge the demand for cell line development equipment. Adoption of incubators with advanced features, such as temperature regulation, high-temperature decontamination, solid copper components and HEFA filters, will further propel the cell line development market demand.

The non-mammalian source segment is poised to show more than a 12% CAGR over 2020 to 2026. It includes insects and amphibians. The insect cell lines are used in various research studies pertaining to virology, hemocyte migration, gene expressions, insecticides, toxicology and activity assay. Commercial availability of insect-derived cell lines for research purposes will, thus, augment the overall industry progress.

The recombinant cell line segment accounted for more than 30% of revenue share in 2019 and is estimated to show significant growth over the coming years. The recombinant cell line consists of recombinant DNA. The advances in rDNA technology offering synthetic hormones, enzymes, immunobiological and anti-cancer agents will favor the market demand. Increasing demand for biopharmaceuticals and biosimilars across the globe will augment the demand for recombinant cell lines.

Browse key industry insights spread across 200 pages with 166 market data tables & 10 figures & charts from the report, "Cell Line Development Market Share & Forecast, 2020 – 2026" in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/cell-line-development-market-report

The Asia-Pacific market is anticipated to witness over a 13% CAGR during the forecast timeframe. The regional business growth is attributed to the presence of a large patient pool suffering from various chronic and infectious diseases. Growing investments in stem cell research, coupled with a surge in demand for regenerative medicine, will favor the regional market progress. Improvements in healthcare infrastructure, as well as favorable government policies in countries such as India and China, will further propel business growth. Increasing adoption of cell line development technologies in biopharmaceutical companies for vaccine and biologics development will fuel the Asia-Pacific cell line development industry growth.

Some major findings of the cell line development market report include:

• The advancements in cell culture media, such as the introduction of three-dimensional cell cultures, has led to the development of stable and fast-growing cell lines.
   
• Adoption of cell lines over primary cells is increasing, owing to longer shelf life, easily propagation and manipulation of the cell lines.
   
• Easy availability of a wide range of cell lines, including pituitary, motor neuron, oligodendrocytes, hippocampal and cardiac endothelial cell lines, will escalate the product demand.
   
• Industry players operating in the cell line development market, such as GE Healthcare, Lonza Group, Sigma-Aldrich Corporation and American Type Culture Collection, among others, adopt various inorganic growth strategies such as mergers and collaborations to capitalize on market opportunities.

Some of the prominent players operating in cell line development market share include Selexis, Vista Biologicals, GE Healthcare, Lonza Group, Sigma-Aldrich Corporation, American Type Culture Collection, EuBiologics, Cobra Biologics, Patheon, Progenitor Cell Therapy, Cyagen, Promocell and Catalent among others. The companies majorly focus on inorganic strategies such as mergers, partnerships, acquisitions and collaboration to expand their product portfolio.

Make an inquiry for purchasing this report at https://www.gminsights.com/inquiry-before-buying/429

Partial chapters of the report's table of contents (TOC):

Chapter 2.    Executive Summary

2.1. Cell line development industry 360° synopsis, 2015 - 2026

2.1.1.    Business trends

2.1.2.    Product trends

2.1.3.    Source trends

2.1.4.    Cell line trends

2.1.5.    Application trends

2.1.6.    Regional trends

Chapter 3.    Cell Line Development Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2015 - 2026

3.3. Industry impact forces

3.3.1.    Growth drivers

3.3.1.1.    Growing vaccine production worldwide

3.3.1.2.    Increasing cancer prevalence in developing countries

3.3.1.3.    Growth in biotechnology industry across the globe

3.3.1.4.    Innovations in biologics due to patent expiration

3.3.1.5.    Rising demand for monoclonal antibodies in developed economies

3.3.1.6.    Technological innovation in cell line development

3.3.2.    Industry pitfalls & challenges

3.3.2.1.    Complex regulatory landscape

3.3.2.2.    Issues related to stem cell research

3.4. Growth potential analysis

3.4.1.    By product

3.4.2.    By source

3.4.3.    By cell line type

3.4.4.    By application

3.5. Porter's analysis

3.6. Competitive landscape

3.6.1.    Strategy dashboard, 2019

3.7. PESTEL analysis

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

GMIPulse, our business analytics platform, offers an online, interactive option of exploring our proprietary industry research data in an easy-to-use and dynamic manner. Clients get to explore market intelligence across 11 top-level categories and hundreds of industry segments within them, covering regional, company-level and cross-sectional statistics that make our offering a stand-out for decision-makers.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: [email protected]

Related Images

cell-line-development-market-to.jpg
Cell Line Development Market to Hit US $9.8B by 2026
Cell Line Development Market size is set to reach USD 9.8 billion by 2026, according to a new research report by Global Market Insights, Inc.

Related Links

Stem Cell Therapy Market

Gene Editing Market

SOURCE Global Market Insights, Inc.

Related Links

https://www.gminsights.com